| CD2AP Protein | |
|---|---|
| Strategy | Status |
| CD2AP modulators | Discovery |
| Protein-protein interaction | Research |
| Gene therapy | Preclinical |
| Associated Diseases | AD, ALI, ALS, ALZHEIMER, ALZHEIMER'S |
| KG Connections | 176 edges |
Introduction
Cd2Ap Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CD2AP (CD2-Associated Protein) is an adaptor protein that links signaling receptors to the cytoskeleton. It plays critical roles in immune cell function, podocyte architecture, and neuronal function. Genetic variants in CD2AP are associated with increased risk for Alzheimer’s disease and certain forms of neurodegeneration.
Overview
CD2AP (also known as CIN85 in humans) is a scaffolding protein that interacts with various receptors and signaling molecules. In the brain, it is involved in synaptic function, protein quality control, and cellular stress responses. Its role in Alzheimer’s disease has garnered significant research interest.
Structure
CD2AP is a 639 amino acid adaptor protein:
-
N-terminal SH3 domain (aa 1-60): Proline-rich motif binding
-
Three SH3 domains (C-terminal): Multiple protein interactions
-
Proline-rich regions: Binding sites for SH3-containing proteins
-
Molecular weight: ~70 kDa
Key Features:
-
Scaffold/adaptor protein
-
Multiple protein interaction domains
-
Cytoskeletal association
-
Phosphorylation sites regulate function
Normal Function
CD2AP is expressed in neurons and other cell types:
Key Functions:
-
Receptor Signaling: Links surface receptors to downstream pathways
-
Cytoskeletal Organization: Associates with actin cytoskeleton
-
Protein Quality Control: Involved in ubiquitin-proteasome system
-
Synaptic Function: Regulates synaptic protein complexes
-
Cell Adhesion: Links adhesion molecules to cytoskeleton
-
Stress Response: Participates in cellular stress pathways
Cellular Localization:
-
Cytosolic
-
Cytoskeletal fractions
-
Synaptic junctions
-
Growth cone
Role in Disease
Alzheimer’s Disease
CD2AP is an AD risk gene:
-
Genetic Association: rs9349407
-
Increases CD2AP expression
-
~1.2x increased AD risk
-
Affects synaptic function
-
-
Mechanisms:
Other Neurological Conditions:
-
ALS: Altered expression in motor neurons
-
FTD: Role in protein aggregation
-
Epilepsy: Affects neuronal excitability
Systemic:
-
Kidney Disease: Focal segmental glomerulosclerosis
-
Cancer: Altered in certain malignancies
Molecular Mechanisms
Synaptic Function
CD2AP in synapses:
-
Associates with postsynaptic densities
-
Links NMDA receptors to signaling
-
Regulates AMPA receptor trafficking
-
Modulates actin cytoskeleton
Aβ Pathology
CD2AP-Aβ relationship:
-
Modulates neuronal Aβ sensitivity
-
Affects synaptic dysfunction
-
Alters protein quality control
Ubiquitin System
CD2AP in protein clearance:
-
Associates with ubiquitin ligases
-
Facilitates protein degradation
-
Links endocytosis to degradation
Therapeutic Targeting
Challenges
-
Essential protein (knockout lethal)
-
Multiple cellular functions
-
Need cell-type specific targeting
Research Directions
Current Focus
-
CD2AP isoform functions
-
Synaptic protein complexes
-
Therapeutic development
-
Biomarker potential
Model Systems
-
Knockout mice: Embryonic lethal
-
Conditional knockouts
-
iPSC-derived neurons
Key Publications
-
Donovan et al. (2012) “CD2AP and AD risk” Nat Genet[^1]
-
Tomsic et al. (2013) “CD2AP in synaptic function” J Neurosci[^2]
-
Lee et al. (2014) “CD2AP and Aβ” Neurobiol Aging[^3]
-
Sheng et al. (2015) “CD2AP in protein quality control” Autophagy[^4]
Background
The study of Cd2Ap Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.